Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Response is tracked by clinical assessment and photography, not by guesswork
W.LeungY
BPC 157 entered early-phase clinical development for inflammatory bowel disease as PL 14736 (Pliva, Croatia), and a 2025 pilot examined intravenous administration in a small cohort, but no adequately powered randomised controlled trial exists
Much of the enthusiasm draws on preclinical work cell cultures and animal models showing wound-healing and tissue-repair effects
Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line
US$ 27.05
.png?sfvrsn=1e7191c0_3)
US$ 25.73
US$ 27.94
